Skip to main content
Premium Trial:

Request an Annual Quote

Metabolon, Trajan Scientific and Medical Strike Comarketing Deal

NEW YORK — Metabolon said on Monday that it has partnered with Australian life science firm Trajan Scientific and Medical to jointly offer remote microsampling services for metabolomics research.

Under the terms of the deal, the companies will comarket Trajan's Neoteryx Mitra collection devices, which are designed for the self-collection of 10, 20, and 30 microliter blood samples, for use with Metabolon's targeted and untargeted metabolomics panels.

A Trajan spokesperson said that the companies have validated the devices for use with Metabolon's panels and that they will also offer support to customers in the design of their research studies or clinical trials.

Additional terms of the deal were not disclosed.

"Our work with Trajan will help researchers access patients more easily through decentralized trials and foster greater adoption of metabolomics," Metabolon CSO Rangaprasad Sarangarajan said in a statement. "Advanced metabolomic analytical techniques can now be applied to a much broader array of academic and commercial life science research."

Earlier this year, Morrisville, North Carolina-based Metabolon introduced two targeted panels, the Bile Acids and Short Chain Fatty Acids panels, that measure microbially derived metabolites to identify biomarkers for the prediction and early detection of a range of diseases.